Both perimenstrual and non-perimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies.
Authors
Verhagen IE, de Vries Lentsch S, Arend BWHV, Cessie SL, MaassenVanDenBrink A, Terwindt GM
Abstract
Anti-CGRP (receptor) antibodies effectively reduce overall migraine attack frequency, but whether there are differences in effect between perimenstrual and non-perimenstrual migraine days has not been investigated.
